PAIGE.AI, Inc.
NEW YORK, NY · Founded 2017 · CIK 0001728144 · Medtech · Acquired
Foundation models and AI algorithms for cancer pathology image analysis and diagnosis
paige.ai →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $108M
- 3 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 21 granted · 19 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $33,689,981 | |
| Private capital raised | Form D · SEC | $55,000,016 | |
| Private capital raised | Form D · SEC | $19,499,894 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1732 | Trevi Therapeutics, Inc. | — | $118M |
| 1733 | EPOULOSIS THERAPEUTICS, INC. | — | — |
| 1734 | ANDE Corp | — | $109M |
| 1735 | PAIGE.AI, Inc. | — | $108M |
| 1736 | EKSO BIONICS HOLDINGS, INC. | — | $103M |
| 1737 | BEAM - CA, LLC | — | — |
| 1738 | LUVOZO PBC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David AndreassonExecutive Officer
- Jim BeyerDirector
- Jim BreyerDirector
- Eli CasdinDirector
- David CastelblancoDirector
- Martin ChavezDirector
- R. ChavezDirector
- Eric CottingtonDirector
- Thomas FuchsDirector · Executive Officer
- Robert GalvinDirector
- Leo GradyDirector · Executive Officer
- Peter HamiltonExecutive Officer
- Hedvig Hricak, M.D., Ph.D.Director
- Thomas KellyDirector
- David KlimstraExecutive Officer
- Carla LeibowitzExecutive Officer
- Jeffrey LightcapDirector
- William MoyeDirector · Executive Officer
- Antoine MunfaDirector
- Alex RobertsonDirector
- Ali SatvatDirector
- Christina SegroExecutive Officer
- Norman SelbyDirector
- Kenan TurnaciogluDirector
- Asish XavierDirector
Patents
- Systems And Methods For Processing Electronic Images With Metadata Integrationgranted
- Systems And Methods For Analyzing Electronic Images For Quality Controlapplication
- Systems And Methods For Processing Electronic Medical Images To Optimize A Review Order Of Pathology Casesapplication
- Systems And Methods To Process Electronic Images For Histological Morphology Trajectory Predictiongranted
- Systems And Methods For Processing Electronic Images For Health Monitoring And Forecastingapplication
- Systems And Methods To Process Electronic Images To Determine Histopathology Qualityapplication
- Systems And Methods To Process Electronic Images To Categorize Intra-slide Specimen Tissue Typegranted
- Systems And Methods For Processing Electronic Images To Identify Transplant Donor-recipient Matchesgranted
- Systems And Methods For Processing Images To Determine Biomarker Levelsapplication
- Systems And Methods To Process Electronic Images With Automatic Protocol Revisionsapplication
- Systems And Methods For Processing Electronic Images To Visualize Combinations Of Semantic Pathology Featuresgranted
- Systems And Methods For Processing Whole Slide Images Using Machine-learninggranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.